FIRESCREEN Study Enrolls Over 800 Firefighters in Cancer Screening Initiative – Dana-Farber Cancer Institute
Dana-Farber Cancer Institute/LinkedIn

FIRESCREEN Study Enrolls Over 800 Firefighters in Cancer Screening Initiative – Dana-Farber Cancer Institute

Dana-Farber Cancer Institute shared on LinkedIn:

“Firefighters face an elevated risk of developing cancer due to occupational exposures. The FIRESCREEN study, led by Elizabeth O’Donnell, and Catherine Marinac, and the Multi-Cancer Early Detection (MCED) Clinic team has enrolled over 800+ firefighters, completing the first phase of this Firefighters First Cancer Screening Initiative in New Hampshire.

The study’s goal is to collect data to help improve health and wellbeing outcomes for firefighters. Firefighters are recruited at the New Hampshire state-sponsored cancer screening program for firefighters which provides targeted screening tailored to their unique risks, improving the likelihood of catching cancers at a treatable stage. Findings from the FIRESCREEN study will support the development of evidence-based screening recommendations for firefighters and help optimize future screening approaches.

Nicholas Reilly, Madeline King, Briella Jackson, and Victoria Kelly, clinical research coordinators with the MCED team, Eric Blackstone, PhD, HEC-C, and Jad Farhoud, research fellows with the MCED team, and Isabella Garver, and Margaret Toscano from Business Strategy spent several weeks in New Hampshire recruiting firefighters to participate in the study.

During their time in New Hampshire, the team also provided information about Direct Connect for Firefighters, our cancer navigation program designed to meet the unique needs of firefighters.

The team’s support helped increase enrollment and played a key role in the phase 1 of the study. Phase 2 is now enrolling Firefighters in New Hampshire.”

FIRESCREEN Study Enrolls Over 800 Firefighters in Cancer Screening Initiative - Dana-Farber Cancer Institute

Other articles from Dana-Farber Cancer Institute on OncoDaily.